Acute Kidney Injury
Acute Kidney Injury
Part of NephTimes
Advertisement
Victoria SochaCOVID-19 and Kidney Disease | May 13, 2024
What is the specific impact of acute kidney injury (AKI) on in-hospital mortality among octogenarian patients with COVID-19?
Read More
Charlotte RobinsonAcute Kidney Injury | April 29, 2024
The FDA gave Breakthrough Device designation to the JuxtaFlow RAD to help prevent AKI during cardiothoracic surgery.
Victoria SochaAcute Kidney Injury | April 29, 2024
Accurate prediction of severe outcomes of acute kidney injury remains challenging.  
Charlotte RobinsonAcute Kidney Injury | April 22, 2024
Opinions differ on the use of no anticoagulation versus regional citrate anticoagulation for treatment of AKI with CKRT.
Victoria SochaAcute Kidney Injury | April 2, 2024
A baseline creatinine measurement from clinical trial enrollment may not be the best way to detect acute kidney injury.
Charlotte RobinsonDiabetes and Hypertension | April 1, 2024
SGLT-2is are associated with reduced risk of mortality in patients with type 2 diabetes and acute kidney disease.
Victoria SochaAcute Kidney Injury | March 14, 2024
Patients who have acute kidney injury while hospitalized face increased risk for morbidity and mortality after discharge.
Charlotte RobinsonAcute Kidney Injury | March 4, 2024
The FDA has granted a Humanitarian Device Exemption Approval Order to the Selective Cytopheretic Device Pediatric.
Alaa DiabCOVID-19 and Kidney Disease | February 12, 2024
Patients hospitalized with COVID-19 face increased risk for long-term adverse outcomes such as major adverse kidney events.
Victoria SochaAcute Kidney Injury | February 5, 2024
Community-acquired acute kidney injury (CA-AKI) is AKI that develops outside of the hospital setting.
Victoria SochaASN Kidney Week 2023 | February 5, 2024
More patients in the terlipressin group had a >30% improvement in serum creatinine from baseline than in the placebo group.
Victoria SochaASN Kidney Week 2023 | February 5, 2024
Effective blood pressure control following AKI may have beneficial effects on outcomes.
Victoria SochaASN Kidney Week 2023 | February 5, 2024
Examining the effect of SGLT2 inhibitors on biomarkers of tubular injury in patients with acute heart failure.
Victoria SochaAcute Kidney Injury | February 5, 2024
The difference in risk between White and Black patients was driven by greater MI risk in Black versus White patients.
Victoria SochaAcute Kidney Injury | February 5, 2024
Perioperative administration of acetaminophen and reduced AKI after cardiac surgery.
Victoria SochaAcute Kidney Injury | February 5, 2024
For all outcomes, rates of health care utilization were higher in the dialysis-treated AKI survivor group than in controls.
Victoria SochaAcute Kidney Injury | February 5, 2024
Patients with COVID-19 had the worst outcomes, with higher rates of death.
Victoria SochaCOVID-19 and Kidney Disease | February 5, 2024
The total incidence of AKI in this cohort was low (n=5/41).
Victoria SochaKidney Transplantation | February 5, 2024
Thirty-seven percent of recipients experienced delayed graft function/
Victoria SochaAcute Kidney Injury | February 5, 2024
The cost per response of terlipressin plus albumin was lower than M&O+albumin and norepi+albumin.
Advertisement
Advertisement
Advertisement
Latest News

May 29, 2024